The European Pharmacopoeia: A Common European Initiative by the Council of Europe
DOI:
https://doi.org/10.2533/000942904777677254Keywords:
Biovalley, European pharmacopoeia, European union directives, Public health, Quality of medicines, TradeAbstract
The European Pharmacopoeia, founded in 1964, ensures the quality and safety of medicines by elaborating compulsory standards, by describing quality control methods, and by making it possible to detect counterfeit medicines. European Pharmacopoeia standards apply to all medicines regardless of their origin, their method of production or their type. The official standards published by the European Pharmacopoeia provide a legal and scientific basis for quality control during the development, production, and marketing of medicines. The establishment of the European Pharmacopoeia in Strasbourg represents an important strategic asset to the BioValley showing the trinational region as an importance life sciences cluster.Downloads
Published
2004-11-01
Issue
Section
Scientific Articles
License
Copyright (c) 2004 Swiss Chemical Society
![Creative Commons License](http://i.creativecommons.org/l/by-nc/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
[1]
C. L. Le Tarnec, Chimia 2004, 58, 798, DOI: 10.2533/000942904777677254.